Detalles de la búsqueda
1.
Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity.
Cancer Immunol Immunother
; 56(12): 1861-73, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17487489
2.
An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia.
Cancer Immunol Immunother
; 55(8): 1017-24, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16450142
3.
IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
Mol Ther
; 11(1): 120-31, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15585413
4.
Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells.
J Virol
; 79(20): 13190-4, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16189021
5.
Immunological weapons against acute myeloid leukaemia.
Immunology
; 107(1): 20-7, 2002 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12225359
6.
Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Cancer Immunol Immunother
; 53(11): 963-77, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15146294
7.
Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination.
Cancer Immunol Immunother
; 51(6): 299-310, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12111118
Resultados
1 -
7
de 7
1
Próxima >
>>